100 related articles for article (PubMed ID: 16467449)
1. Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.
Kondo S; Shimizu M; Urushihara M; Tsuchiya K; Yoshizumi M; Tamaki T; Nishiyama A; Kawachi H; Shimizu F; Quinn MT; Lambeth DJ; Kagami S
J Am Soc Nephrol; 2006 Mar; 17(3):783-94. PubMed ID: 16467449
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
[TBL] [Abstract][Full Text] [Related]
3. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
4. Candesartan prevents the progression of mesangioproliferative nephritis in rats.
Nakamura T; Obata J; Onizuka M; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int Suppl; 1997 Dec; 63():S226-8. PubMed ID: 9407466
[TBL] [Abstract][Full Text] [Related]
5. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
[TBL] [Abstract][Full Text] [Related]
6. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats.
Leh S; Vaagnes Ø; Margolin SB; Iversen BM; Forslund T
Nephrol Dial Transplant; 2005 Jan; 20(1):71-82. PubMed ID: 15561744
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
9. ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis.
Urushihara M; Takamatsu M; Shimizu M; Kondo S; Kinoshita Y; Suga K; Kitamura A; Matsuura S; Yoshizumi M; Tamaki T; Kawachi H; Kagami S
Am J Physiol Renal Physiol; 2010 Jan; 298(1):F167-76. PubMed ID: 19846573
[TBL] [Abstract][Full Text] [Related]
10. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis.
Krämer S; Kron S; Wang-Rosenke Y; Loof T; Khadzhynov D; Morgera S; Kawachi H; Shimizu F; Martini S; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F801-11. PubMed ID: 18216152
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria.
Benigni A; Corna D; Zoja C; Longaretti L; Gagliardini E; Perico N; Coffman TM; Remuzzi G
J Am Soc Nephrol; 2004 Oct; 15(10):2666-74. PubMed ID: 15466271
[TBL] [Abstract][Full Text] [Related]
14. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
15. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
[TBL] [Abstract][Full Text] [Related]
18. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
19. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
